Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells
ABSTRACT Background Methylthioadenosine phosphorylase (MTAP) and protein arginine methyltransferase 5 (PRMT5) are considered to be a synthetic lethal pair of targets, due to the fact that deletion of MTAP leads to massive production of methylthioadenosine (MTA) decreasing the activity of PRMT5. In v...
Saved in:
Main Authors: | Yunjie Wang, Xiaohui Sun, Runchen Ma, Xiaofan Zhang, Shengmin Ji, Zhaofeng Liu, Gangqiang Yang, Hongbo Wang, Peng Zhang, Jianzhao Zhang, Jingwei Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70526 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
by: Kimberly J. Briggs, et al.
Published: (2025-02-01) -
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
by: Natalia Gorbokon, et al.
Published: (2025-01-01) -
Use of the mineral trioxide aggregate (MTA) in teeth with apical incomplete formation
by: Lissete Liliana Mendoza Cama, et al.
Published: (2018-10-01) -
PRMT6 promotes colorectal cancer progress via activating MYC signaling
by: Xin Zhang, et al.
Published: (2025-01-01) -
Capability of biodentine and the mineral trioxide aggregate mta sealing in furcal perforation repair. Literature review
by: Silvana Benavides, et al.
Published: (2018-10-01)